US Stock MarketDetailed Quotes
SLN Silence Therapeutics
- 6.750
- -0.130-1.89%
Trading Dec 23 15:48 ET
318.70MMarket Cap-3.99P/E (TTM)
7.000High6.540Low278.24KVolume6.890Open6.880Pre Close1.87MTurnover1.09%Turnover RatioLossP/E (Static)47.21MShares27.72052wk High2.68P/B172.92MFloat Cap5.81052wk Low--Dividend TTM25.62MShs Float35.000Historical High--Div YieldTTM6.69%Amplitude4.545Historical Low6.709Avg Price1Lot Size
Silence Therapeutics Key Stats
EPS
According to the latest financial report of Silence Therapeutics, the latest earnings per share (TTM) for the company is -0.57. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: GBP
Quarterly
Loading...
FCF
Interested in knowing about Silence Therapeutics's free cash flow? The latest report shows it as -19.71M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: GBP
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Silence Therapeutics shows that the company's current ratio is 9.31, indicating healthy liquidity.
Currency: GBP
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Silence Therapeutics, the quick ratio is 8.61, indicating that the company can meet its short-term debt obligations.
Currency: GBP
Quarterly
Loading...
ROE
Want to learn more about the financial health of Silence Therapeutics? The latest ROE figure is -26.10%, indicating that the company has stable profitability.
Currency: GBP
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Silence Therapeutics, the total asset return on investment (ROA) is -15.09%.
Currency: GBP
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Silence Therapeutics's latest financial report to see how their gross margin is doing - currently at -142.91%.
Currency: GBP
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Silence Therapeutics, the net profit margin is -2.37K%, which is a good sign for its profitability.
Currency: GBP
Quarterly
Loading...
Heat List
US
Overall
Symbol
Price
% Chg
No Data